Advertisement

Index by author

January 01, 1985; Volume 232,Issue 1

A

  1. Abdel-Aziz, S A

    1. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.
      A Mukhopadhyay, S S Navran, H M Amin, S A Abdel-Aziz, J Chang, D J Sober, D D Miller and D R Feller
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 1-9;

  2. Abdel-Rahman, A R

    1. Effect of chronic ethanol administration on arterial baroreceptor function and pressor and depressor responsiveness in rats.
      A R Abdel-Rahman, M S Dar and W R Wooles
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 194-201;

  3. Abernethy, D R

    1. Imipramine and desipramine disposition in the elderly.
      D R Abernethy, D J Greenblatt and R I Shader
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 183-188;

  4. Aiken, D L

    1. Changes in histidine uptake and histamine synthesis during the growth cycle of rat basophilic leukemia (2H3) cells.
      E Woldemussie, D L Aiken and M A Beaven
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 20-26;

  5. Amin, H M

    1. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.
      A Mukhopadhyay, S S Navran, H M Amin, S A Abdel-Aziz, J Chang, D J Sober, D D Miller and D R Feller
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 1-9;

  6. Arlock, P

    1. Amrinone effects on electromechanical coupling and depolarization-induced automaticity in ventricular muscle of guinea pigs and ferrets.
      C O Malécot, P Arlock and B G Katzung
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 10-19;

  7. Arnsdorf, M F

    1. Effects of encainide on the determinants of cardiac excitability in sheep Purkinje fibers.
      M F Arnsdorf, G A Schmidt and G J Sawicki
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 40-48;

  8. Askar, A O

    1. Evidence suggesting an Ra-type adenosine receptor in bovine coronary arteries.
      S J Mustafa and A O Askar
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 49-56;

  9. Atal, C K

    1. Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism.
      C K Atal, R K Dubey and J Singh
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 258-262;

B

  1. Baizer, L

    1. Description and analysis of the myotonolytic effects of phenytoin in the decerebrate cat: implications for potential utility of phenytoin in spastic disorders.
      A Raines, T M Mahany, L Baizer, S Swope and N Hershkowitz
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 283-294;

  2. Baum, T

    1. Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog.
      E J Sybertz, R W Watkins, T Baum, K Pula and M Rivelli
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 156-162;

  3. Beaven, M A

    1. Changes in histidine uptake and histamine synthesis during the growth cycle of rat basophilic leukemia (2H3) cells.
      E Woldemussie, D L Aiken and M A Beaven
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 20-26;

  4. Bertko, R J

    1. Effect of the synthetic prostanoid Ro 22-6923 on gastric secretion and blood flow in Heidenhain pouch dogs.
      T S Gaginella, R J Bertko, R K Müller, H Gallo-Torres and A C Sullivan
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 208-213;

  5. Bewtra, A

    1. Tissue distribution and functional correlation of [3H]leukotriene C4 and [3H]leukotriene D4 binding sites in guinea-pig uterus and lung preparations.
      J B Cheng, D Lang, A Bewtra and R G Townley
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 80-87;

C

  1. Cavalla, D

    1. Co-localized adenosine A1 and gamma-aminobutyric acid B (GABAB) receptors of cerebellum may share a common adenylate cyclase catalytic unit.
      W J Wojcik, D Cavalla and N H Neff
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 62-66;

  2. Chang, J

    1. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.
      A Mukhopadhyay, S S Navran, H M Amin, S A Abdel-Aziz, J Chang, D J Sober, D D Miller and D R Feller
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 1-9;

  3. Cheng, J B

    1. Tissue distribution and functional correlation of [3H]leukotriene C4 and [3H]leukotriene D4 binding sites in guinea-pig uterus and lung preparations.
      J B Cheng, D Lang, A Bewtra and R G Townley
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 80-87;

  4. Churchill, P C

    1. Concentration dependency of the renal vascular and renin secretory responses to adenosine receptor agonists.
      R D Murray and P C Churchill
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 189-193;

D

  1. Dar, M S

    1. Effect of chronic ethanol administration on arterial baroreceptor function and pressor and depressor responsiveness in rats.
      A R Abdel-Rahman, M S Dar and W R Wooles
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 194-201;

  2. Decker, N

    1. Postjunctional alpha-1 and alpha-2 adrenoceptors in the coronaries of the perfused guinea-pig heart.
      N Decker and J Schwartz
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 251-257;

  3. Desjardins, D

    1. Muscarinic cholinergic receptors in mouse pituitary tumor cells: prolonged agonist pretreatment decreases receptor content and increases forskolin- and hormone-stimulated cyclic AMP synthesis and adrenocorticotropin secretion.
      S Heisler, D Desjardins and M H Nguyen
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 232-238;

  4. Distefano, V

    1. Pharmacological action of radiographic contrast media reduced cerebrospinal fluid production in the dog.
      P P Harnish and V Distefano
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 88-93;

  5. Dubey, R K

    1. Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism.
      C K Atal, R K Dubey and J Singh
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 258-262;

E

  1. Ellingboe, J

    1. Acute effects of marihuana smoking on prolactin levels in human females.
      J H Mendelson, N K Mello and J Ellingboe
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 220-222;

  2. Enas, G G

    1. Clinical pharmacology of tomoxetine, a potential antidepressant.
      R L Zerbe, H Rowe, G G Enas, D Wong, N Farid and L Lemberger
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 139-143;

F

  1. Fanelli, R J

    1. Comparison of the effects of diphenylbarbituric acid, phenobarbital, pentobarbital and secobarbital on GABA-mediated inhibition and benzodiazepine binding.
      M J Iadarola, R J Fanelli, J O McNamara and W A Wilson
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 127-133;

  2. Farid, N

    1. Clinical pharmacology of tomoxetine, a potential antidepressant.
      R L Zerbe, H Rowe, G G Enas, D Wong, N Farid and L Lemberger
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 139-143;

  3. Feller, D R

    1. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.
      A Mukhopadhyay, S S Navran, H M Amin, S A Abdel-Aziz, J Chang, D J Sober, D D Miller and D R Feller
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 1-9;

  4. Fujimoto, J M

    1. Differential actions of intrathecal naloxone on blocking the tail-flick inhibition induced by intraventricular beta-endorphin and morphine in rats.
      L F Tseng and J M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 74-79;

G

  1. Gaginella, T S

    1. Inhibition of acid secretion and gastric lesions in rats by the prostanoid Ro 22-6923.
      T S Gaginella, R K Müller, C G Witt, P Rosen, G W Holland, H Gallo-Torres and A C Sullivan
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 202-207;
    2. Effect of the synthetic prostanoid Ro 22-6923 on gastric secretion and blood flow in Heidenhain pouch dogs.
      T S Gaginella, R J Bertko, R K Müller, H Gallo-Torres and A C Sullivan
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 208-213;

  2. Gallo-Torres, H

    1. Inhibition of acid secretion and gastric lesions in rats by the prostanoid Ro 22-6923.
      T S Gaginella, R K Müller, C G Witt, P Rosen, G W Holland, H Gallo-Torres and A C Sullivan
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 202-207;
    2. Effect of the synthetic prostanoid Ro 22-6923 on gastric secretion and blood flow in Heidenhain pouch dogs.
      T S Gaginella, R J Bertko, R K Müller, H Gallo-Torres and A C Sullivan
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 208-213;

  3. George, R

    1. Identification of multiple opiate receptors through neuroendocrine responses. I. Effects of agonists.
      R Pechnick, R George and R E Poland
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 163-169;
    2. Identification of multiple opiate receptors through neuroendocrine responses. II. Antagonism of mu, kappa and sigma agonists by naloxone and WIN 44,441-3.
      R Pechnick, R George and R E Poland
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 170-177;

  4. Goldstein, A

    1. Antinociception and paralysis induced by intrathecal dynorphin A.
      B H Herman and A Goldstein
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 27-32;

  5. Greenblatt, D J

    1. Imipramine and desipramine disposition in the elderly.
      D R Abernethy, D J Greenblatt and R I Shader
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 183-188;

H

  1. Hall, S

    1. Influence of fraction unbound upon the renal clearance of furosemide in the isolated perfused rat kidney.
      S Hall and M Rowland
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 263-268;

  2. Harnish, P P

    1. Pharmacological action of radiographic contrast media reduced cerebrospinal fluid production in the dog.
      P P Harnish and V Distefano
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 88-93;

  3. Heckman, G D

    1. Antidiuretic hormone antagonists and aquaresis in dogs: different vasopressin sensitivity and antagonist potency in renal cortex and papilla.
      F L Stassen, G D Heckman, W F Huffman and L B Kinter
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 100-105;

  4. Heisler, S

    1. Muscarinic cholinergic receptors in mouse pituitary tumor cells: prolonged agonist pretreatment decreases receptor content and increases forskolin- and hormone-stimulated cyclic AMP synthesis and adrenocorticotropin secretion.
      S Heisler, D Desjardins and M H Nguyen
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 232-238;

  5. Herman, B H

    1. Antinociception and paralysis induced by intrathecal dynorphin A.
      B H Herman and A Goldstein
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 27-32;

  6. Hershkowitz, N

    1. Description and analysis of the myotonolytic effects of phenytoin in the decerebrate cat: implications for potential utility of phenytoin in spastic disorders.
      A Raines, T M Mahany, L Baizer, S Swope and N Hershkowitz
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 283-294;

  7. Hoch, D H

    1. Neuropharmacological characterization of fragment B from tetanus toxin.
      L L Simpson and D H Hoch
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 223-227;

  8. Holland, G W

    1. Inhibition of acid secretion and gastric lesions in rats by the prostanoid Ro 22-6923.
      T S Gaginella, R K Müller, C G Witt, P Rosen, G W Holland, H Gallo-Torres and A C Sullivan
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 202-207;

  9. Huff, R M

    1. Assay of dopamine receptors with [alpha-3H]flupenthixol.
      R M Huff and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 57-61;

  10. Huffman, W F

    1. Antidiuretic hormone antagonists and aquaresis in dogs: different vasopressin sensitivity and antagonist potency in renal cortex and papilla.
      F L Stassen, G D Heckman, W F Huffman and L B Kinter
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 100-105;

  11. Huguenard, J R

    1. Suppression of repetitive firing of neurons by diphenylbarbituric acid.
      J R Huguenard and W A Wilson
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 228-231;

I

  1. Iadarola, M J

    1. Comparison of the effects of diphenylbarbituric acid, phenobarbital, pentobarbital and secobarbital on GABA-mediated inhibition and benzodiazepine binding.
      M J Iadarola, R J Fanelli, J O McNamara and W A Wilson
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 127-133;

J

  1. Jung, D

    1. Disposition of acetaminophen in protein-calorie malnutrition.
      D Jung
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 178-182;

K

  1. Kacew, S

    1. Gentamicin or chlorphentermine induction of phospholipidosis in the developing organism: role of tissue and species in manifestation of toxicity.
      S Kacew
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 239-243;

  2. Katzung, B G

    1. Amrinone effects on electromechanical coupling and depolarization-induced automaticity in ventricular muscle of guinea pigs and ferrets.
      C O Malécot, P Arlock and B G Katzung
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 10-19;

  3. Kimura, T

    1. Inhibitory effect of quinacrine on myocardial reactive hyperemia in the dog.
      T Kimura and S Satoh
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 269-274;

  4. Kinter, L B

    1. Antidiuretic hormone antagonists and aquaresis in dogs: different vasopressin sensitivity and antagonist potency in renal cortex and papilla.
      F L Stassen, G D Heckman, W F Huffman and L B Kinter
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 100-105;

  5. Kurz, K

    1. Evaluation of a novel antihypertensive agent, LY127210, in anesthetized and conscious spontaneously hypertensive rats.
      R R Ruffolo, K Kurz and C J Paget
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 134-138;

L

  1. Lal, H

    1. Discriminative stimuli produced by clonidine in spontaneously hypertensive rats: generalization to antihypertensive drugs with different mechanisms of action.
      H Lal and S Yaden
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 33-39;

  2. Lang, D

    1. Tissue distribution and functional correlation of [3H]leukotriene C4 and [3H]leukotriene D4 binding sites in guinea-pig uterus and lung preparations.
      J B Cheng, D Lang, A Bewtra and R G Townley
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 80-87;

  3. Lemberger, L

    1. Clinical pharmacology of tomoxetine, a potential antidepressant.
      R L Zerbe, H Rowe, G G Enas, D Wong, N Farid and L Lemberger
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 139-143;

  4. Ling, G S

    1. Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms.
      G S Ling, K Spiegel, S H Lockhart and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 149-155;

  5. Lockhart, S H

    1. Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms.
      G S Ling, K Spiegel, S H Lockhart and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 149-155;

M

  1. Mahany, T M

    1. Description and analysis of the myotonolytic effects of phenytoin in the decerebrate cat: implications for potential utility of phenytoin in spastic disorders.
      A Raines, T M Mahany, L Baizer, S Swope and N Hershkowitz
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 283-294;

  2. Malécot, C O

    1. Amrinone effects on electromechanical coupling and depolarization-induced automaticity in ventricular muscle of guinea pigs and ferrets.
      C O Malécot, P Arlock and B G Katzung
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 10-19;

  3. McNamara, J O

    1. Comparison of the effects of diphenylbarbituric acid, phenobarbital, pentobarbital and secobarbital on GABA-mediated inhibition and benzodiazepine binding.
      M J Iadarola, R J Fanelli, J O McNamara and W A Wilson
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 127-133;

  4. Mello, N K

    1. Acute effects of marihuana smoking on prolactin levels in human females.
      J H Mendelson, N K Mello and J Ellingboe
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 220-222;

  5. Mendelson, J H

    1. Acute effects of marihuana smoking on prolactin levels in human females.
      J H Mendelson, N K Mello and J Ellingboe
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 220-222;

  6. Messick, K

    1. Evaluation of the alpha-1 and alpha-2 adrenoceptor-mediated effects of a series of dimethoxy-substituted tolazoline derivatives in the cardiovascular system of the pithed rat.
      R R Ruffolo and K Messick
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 94-99;

  7. Miller, D D

    1. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.
      A Mukhopadhyay, S S Navran, H M Amin, S A Abdel-Aziz, J Chang, D J Sober, D D Miller and D R Feller
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 1-9;

  8. Molinoff, P B

    1. Assay of dopamine receptors with [alpha-3H]flupenthixol.
      R M Huff and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 57-61;

  9. Mukhopadhyay, A

    1. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.
      A Mukhopadhyay, S S Navran, H M Amin, S A Abdel-Aziz, J Chang, D J Sober, D D Miller and D R Feller
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 1-9;

  10. Müller, R K

    1. Inhibition of acid secretion and gastric lesions in rats by the prostanoid Ro 22-6923.
      T S Gaginella, R K Müller, C G Witt, P Rosen, G W Holland, H Gallo-Torres and A C Sullivan
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 202-207;
    2. Effect of the synthetic prostanoid Ro 22-6923 on gastric secretion and blood flow in Heidenhain pouch dogs.
      T S Gaginella, R J Bertko, R K Müller, H Gallo-Torres and A C Sullivan
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 208-213;

  11. Murray, R D

    1. Concentration dependency of the renal vascular and renin secretory responses to adenosine receptor agonists.
      R D Murray and P C Churchill
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 189-193;

  12. Mustafa, S J

    1. Evidence suggesting an Ra-type adenosine receptor in bovine coronary arteries.
      S J Mustafa and A O Askar
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 49-56;

N

  1. Nathanson, J A

    1. Differential inhibition of beta adrenergic receptors in human and rabbit ciliary process and heart.
      J A Nathanson
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 119-126;

  2. Navran, S S

    1. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.
      A Mukhopadhyay, S S Navran, H M Amin, S A Abdel-Aziz, J Chang, D J Sober, D D Miller and D R Feller
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 1-9;

  3. Neff, N H

    1. Co-localized adenosine A1 and gamma-aminobutyric acid B (GABAB) receptors of cerebellum may share a common adenylate cyclase catalytic unit.
      W J Wojcik, D Cavalla and N H Neff
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 62-66;

  4. Nguyen, M H

    1. Muscarinic cholinergic receptors in mouse pituitary tumor cells: prolonged agonist pretreatment decreases receptor content and increases forskolin- and hormone-stimulated cyclic AMP synthesis and adrenocorticotropin secretion.
      S Heisler, D Desjardins and M H Nguyen
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 232-238;

P

  1. Paget, C J

    1. Evaluation of a novel antihypertensive agent, LY127210, in anesthetized and conscious spontaneously hypertensive rats.
      R R Ruffolo, K Kurz and C J Paget
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 134-138;

  2. Pasternak, G W

    1. Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms.
      G S Ling, K Spiegel, S H Lockhart and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 149-155;

  3. Patrick, G A

    1. Continuous intraperitoneal infusion of pentobarbital: a model of barbiturate dependence in the rat.
      G J Yutrzenka, G A Patrick and W Rosenberger
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 111-118;

  4. Pechnick, R

    1. Identification of multiple opiate receptors through neuroendocrine responses. I. Effects of agonists.
      R Pechnick, R George and R E Poland
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 163-169;
    2. Identification of multiple opiate receptors through neuroendocrine responses. II. Antagonism of mu, kappa and sigma agonists by naloxone and WIN 44,441-3.
      R Pechnick, R George and R E Poland
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 170-177;

  5. Poland, R E

    1. Identification of multiple opiate receptors through neuroendocrine responses. I. Effects of agonists.
      R Pechnick, R George and R E Poland
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 163-169;
    2. Identification of multiple opiate receptors through neuroendocrine responses. II. Antagonism of mu, kappa and sigma agonists by naloxone and WIN 44,441-3.
      R Pechnick, R George and R E Poland
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 170-177;

  6. Pula, K

    1. Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog.
      E J Sybertz, R W Watkins, T Baum, K Pula and M Rivelli
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 156-162;

R

  1. Raines, A

    1. Description and analysis of the myotonolytic effects of phenytoin in the decerebrate cat: implications for potential utility of phenytoin in spastic disorders.
      A Raines, T M Mahany, L Baizer, S Swope and N Hershkowitz
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 283-294;

  2. Reisine, T

    1. Pertussis toxin treatment blocks the inhibition of somatostatin and increases the stimulation by forskolin of cyclic AMP accumulation and adrenocorticotropin secretion from mouse anterior pituitary tumor cells.
      T Reisine, Y L Zhang and R Sekura
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 275-282;

  3. Ringdahl, B

    1. Structural requirements for muscarinic receptor occupation and receptor activation by oxotremorine analogs in the guinea-pig ileum.
      B Ringdahl
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 67-73;

  4. Rivelli, M

    1. Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog.
      E J Sybertz, R W Watkins, T Baum, K Pula and M Rivelli
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 156-162;

  5. Rosen, P

    1. Inhibition of acid secretion and gastric lesions in rats by the prostanoid Ro 22-6923.
      T S Gaginella, R K Müller, C G Witt, P Rosen, G W Holland, H Gallo-Torres and A C Sullivan
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 202-207;

  6. Rosenberger, W

    1. Continuous intraperitoneal infusion of pentobarbital: a model of barbiturate dependence in the rat.
      G J Yutrzenka, G A Patrick and W Rosenberger
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 111-118;

  7. Rowe, H

    1. Clinical pharmacology of tomoxetine, a potential antidepressant.
      R L Zerbe, H Rowe, G G Enas, D Wong, N Farid and L Lemberger
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 139-143;

  8. Rowland, M

    1. Influence of fraction unbound upon the renal clearance of furosemide in the isolated perfused rat kidney.
      S Hall and M Rowland
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 263-268;

  9. Ruffolo, R R

    1. Evaluation of the alpha-1 and alpha-2 adrenoceptor-mediated effects of a series of dimethoxy-substituted tolazoline derivatives in the cardiovascular system of the pithed rat.
      R R Ruffolo and K Messick
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 94-99;
    2. Evaluation of a novel antihypertensive agent, LY127210, in anesthetized and conscious spontaneously hypertensive rats.
      R R Ruffolo, K Kurz and C J Paget
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 134-138;

  10. Rutledge, C O

    1. Antagonism of the positive chronotropic effect of norepinephrine by purine nucleosides in rat atria.
      M K Samet and C O Rutledge
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 106-110;

S

  1. Sabatini, S

    1. Cellular mechanisms of drug-induced papillary necrosis.
      S Sabatini
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 214-219;

  2. Samet, M K

    1. Antagonism of the positive chronotropic effect of norepinephrine by purine nucleosides in rat atria.
      M K Samet and C O Rutledge
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 106-110;

  3. Satoh, K

    1. Is antagonism by Bay k 8644 of the negative dromotropic effect of nifedipine pharmacological?
      N Taira, Y Wada and K Satoh
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 244-250;

  4. Satoh, S

    1. Inhibitory effect of quinacrine on myocardial reactive hyperemia in the dog.
      T Kimura and S Satoh
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 269-274;

  5. Sawicki, G J

    1. Effects of encainide on the determinants of cardiac excitability in sheep Purkinje fibers.
      M F Arnsdorf, G A Schmidt and G J Sawicki
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 40-48;

  6. Schmidt, G A

    1. Effects of encainide on the determinants of cardiac excitability in sheep Purkinje fibers.
      M F Arnsdorf, G A Schmidt and G J Sawicki
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 40-48;

  7. Schwartz, J

    1. Postjunctional alpha-1 and alpha-2 adrenoceptors in the coronaries of the perfused guinea-pig heart.
      N Decker and J Schwartz
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 251-257;

  8. Sekura, R

    1. Pertussis toxin treatment blocks the inhibition of somatostatin and increases the stimulation by forskolin of cyclic AMP accumulation and adrenocorticotropin secretion from mouse anterior pituitary tumor cells.
      T Reisine, Y L Zhang and R Sekura
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 275-282;

  9. Shader, R I

    1. Imipramine and desipramine disposition in the elderly.
      D R Abernethy, D J Greenblatt and R I Shader
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 183-188;

  10. Simpson, L L

    1. Neuropharmacological characterization of fragment B from tetanus toxin.
      L L Simpson and D H Hoch
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 223-227;

  11. Singh, J

    1. Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism.
      C K Atal, R K Dubey and J Singh
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 258-262;

  12. Sober, D J

    1. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.
      A Mukhopadhyay, S S Navran, H M Amin, S A Abdel-Aziz, J Chang, D J Sober, D D Miller and D R Feller
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 1-9;

  13. Spiegel, K

    1. Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms.
      G S Ling, K Spiegel, S H Lockhart and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 149-155;

  14. Stassen, F L

    1. Antidiuretic hormone antagonists and aquaresis in dogs: different vasopressin sensitivity and antagonist potency in renal cortex and papilla.
      F L Stassen, G D Heckman, W F Huffman and L B Kinter
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 100-105;

  15. Su, T P

    1. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
      T P Su
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 144-148;

  16. Sullivan, A C

    1. Inhibition of acid secretion and gastric lesions in rats by the prostanoid Ro 22-6923.
      T S Gaginella, R K Müller, C G Witt, P Rosen, G W Holland, H Gallo-Torres and A C Sullivan
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 202-207;
    2. Effect of the synthetic prostanoid Ro 22-6923 on gastric secretion and blood flow in Heidenhain pouch dogs.
      T S Gaginella, R J Bertko, R K Müller, H Gallo-Torres and A C Sullivan
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 208-213;

  17. Swope, S

    1. Description and analysis of the myotonolytic effects of phenytoin in the decerebrate cat: implications for potential utility of phenytoin in spastic disorders.
      A Raines, T M Mahany, L Baizer, S Swope and N Hershkowitz
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 283-294;

  18. Sybertz, E J

    1. Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog.
      E J Sybertz, R W Watkins, T Baum, K Pula and M Rivelli
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 156-162;

T

  1. Taira, N

    1. Is antagonism by Bay k 8644 of the negative dromotropic effect of nifedipine pharmacological?
      N Taira, Y Wada and K Satoh
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 244-250;

  2. Townley, R G

    1. Tissue distribution and functional correlation of [3H]leukotriene C4 and [3H]leukotriene D4 binding sites in guinea-pig uterus and lung preparations.
      J B Cheng, D Lang, A Bewtra and R G Townley
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 80-87;

  3. Tseng, L F

    1. Differential actions of intrathecal naloxone on blocking the tail-flick inhibition induced by intraventricular beta-endorphin and morphine in rats.
      L F Tseng and J M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 74-79;

W

  1. Wada, Y

    1. Is antagonism by Bay k 8644 of the negative dromotropic effect of nifedipine pharmacological?
      N Taira, Y Wada and K Satoh
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 244-250;

  2. Watkins, R W

    1. Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog.
      E J Sybertz, R W Watkins, T Baum, K Pula and M Rivelli
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 156-162;

  3. Wilson, W A

    1. Comparison of the effects of diphenylbarbituric acid, phenobarbital, pentobarbital and secobarbital on GABA-mediated inhibition and benzodiazepine binding.
      M J Iadarola, R J Fanelli, J O McNamara and W A Wilson
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 127-133;
    2. Suppression of repetitive firing of neurons by diphenylbarbituric acid.
      J R Huguenard and W A Wilson
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 228-231;

  4. Witt, C G

    1. Inhibition of acid secretion and gastric lesions in rats by the prostanoid Ro 22-6923.
      T S Gaginella, R K Müller, C G Witt, P Rosen, G W Holland, H Gallo-Torres and A C Sullivan
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 202-207;

  5. Wojcik, W J

    1. Co-localized adenosine A1 and gamma-aminobutyric acid B (GABAB) receptors of cerebellum may share a common adenylate cyclase catalytic unit.
      W J Wojcik, D Cavalla and N H Neff
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 62-66;

  6. Woldemussie, E

    1. Changes in histidine uptake and histamine synthesis during the growth cycle of rat basophilic leukemia (2H3) cells.
      E Woldemussie, D L Aiken and M A Beaven
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 20-26;

  7. Wong, D

    1. Clinical pharmacology of tomoxetine, a potential antidepressant.
      R L Zerbe, H Rowe, G G Enas, D Wong, N Farid and L Lemberger
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 139-143;

  8. Wooles, W R

    1. Effect of chronic ethanol administration on arterial baroreceptor function and pressor and depressor responsiveness in rats.
      A R Abdel-Rahman, M S Dar and W R Wooles
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 194-201;

Y

  1. Yaden, S

    1. Discriminative stimuli produced by clonidine in spontaneously hypertensive rats: generalization to antihypertensive drugs with different mechanisms of action.
      H Lal and S Yaden
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 33-39;

  2. Yutrzenka, G J

    1. Continuous intraperitoneal infusion of pentobarbital: a model of barbiturate dependence in the rat.
      G J Yutrzenka, G A Patrick and W Rosenberger
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 111-118;

Z

  1. Zerbe, R L

    1. Clinical pharmacology of tomoxetine, a potential antidepressant.
      R L Zerbe, H Rowe, G G Enas, D Wong, N Farid and L Lemberger
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 139-143;

  2. Zhang, Y L

    1. Pertussis toxin treatment blocks the inhibition of somatostatin and increases the stimulation by forskolin of cyclic AMP accumulation and adrenocorticotropin secretion from mouse anterior pituitary tumor cells.
      T Reisine, Y L Zhang and R Sekura
      Journal of Pharmacology and Experimental Therapeutics January 1985, 232 (1) 275-282;
Back to top

In this issue

Advertisement